Articles by Rich Whitworth - Pharmaceutical Executive

ADVERTISEMENT

Articles by Rich Whitworth

Rich Whitworth


Rich Whitworth is the Editor in Chief of Pharmaceutical Technology Europe.

Teva Snatches Cephalon from Valeant
May 5, 2011

Israel-based Teva Industries seals deal to acquire Cephalon for $6.8 billion.

ADVERTISEMENT

Click here